Essential mixed cryoglobulinemia type II

Clinical and Experimental Rheumatology

Volumn 24, Issue 3, 2006, Pages 329-332

  Rozin, Alexander P ^a   Lewin, Mosche ^a   Braun Moscovici, Yolanda ^a   Itzhak, Ofer Ben ^a   Bergman, Reuven ^a   Balbir Gurman, Alexandra ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Colchicine; Coombs positive hemolytic anemia; Essential mixed cryoglobulinemia type II; Low antigen content diet; Membranous proliferative glomerulonephritis type I; Ramipril

Indexed keywords

CEFUROXIME; COLCHICINE; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENT; RAMIPRIL;

AGED; ARTHRITIS; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; COOMBS POSITIVE HEMOLYTIC ANEMIA; CRYOGLOBULINEMIA; CRYOPRECIPITATE; DIET THERAPY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG RESPONSE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; LEUKOCYTOCLASTIC VASCULITIS; MAXIMUM PERMISSIBLE DOSE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; NORMOCHROMIC NORMOCYTIC ANEMIA; PRIORITY JOURNAL; PROTEINURIA; PURPURA; RHEUMATIC DISEASE; SKIN BIOPSY; TREATMENT RESPONSE; URINALYSIS; URINARY TRACT INFECTION;

AGED; ANEMIA, HEMOLYTIC; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIGENS; ANTIRHEUMATIC AGENTS; COLCHICINE; COMBINED MODALITY THERAPY; COOMBS' TEST; CRYOGLOBULINEMIA; DRUG THERAPY, COMBINATION; FEMALE; FOOD, FORMULATED; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HUMANS; HYDROXYCHLOROQUINE; RAMIPRIL; TREATMENT OUTCOME; VASCULITIS, HYPERSENSITIVITY;

EID: 33746594477     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. FABRIZI F, COLUCCI P, PONTICELLI C, LOCATELLI F: Kidney and liver involvement in cryoglobulinemia. Semin Nephrol 2002; 22: 309-18.
2. FERRI C, PIETROGRANDE M, CECCHETTI R et al.: Low antigen content diet in the treatment of patients with mixed cryoglobulinemia. Am J Med 1989; 87: 519-24.
3. FERRI C, GIUGGIOLI D, CAZZATO M, SEBASTIANI M, MASCIA MT, ZIGNEGO AL: HCV-related cryoglobulinemic vasculitis: An update on its etiopathogenesis and therapeutic strategies. Clin Exp Rheumatol 2003; 21 (Suppl. 31): S78-S84.
4. TAVONI A, MOSCA M, FERRI C et al.: Guidelines for the management of essential mixed cryoglobulinemia. Clin Exp Rheumatol 1995; 13S13: 191-5.
5. CASATO M, LILLI D, DONATO G et al.: Occult hepatitis C virus infection in type II mixed cryoglobulinaemia. J Viral Hepat 2003; 10: 455-9.
6. FORNASIERI A, LI M, ARMELLONI S et al.: Glomerulonephritis induced by human IgM K-IgG cryoglobulins in mice. Lab Invest 1993; 69: 531-40.
7. DOLCHER MP, MARCHINI B, SABBATINI A et al.: Autoantibodies from mixed cryoglobulinemia patients bind glomerular antigens. Clin Exp Immunol 1994; 96: 317-22.
8. MIGLIORINI P, PRATESI F, MOSCATO S et al.: Mechanisms of renal damage in mixed cryoglobulinemia nephritis. Nephrol Dial Transplant 2001; 16: 58-9.
9. DI STASIO E, BIZZARRI P, CASATO M, GALTIERI A, FIORILLI M, PUCILLO LP: Cl-regulates cryoglobulin structure: a new hypothesis for the physiopathological mechanism of temperature non-dependent cryoprecipitation. Clin Chem Lab Med 2004; 42: 614-20.
10. ZAJA F, DE VITA S, MAZZARO C et al.: Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood 2003; 101: 3827-34.